Rhinomed is an ASX listed (RNO:AU) Melbourne Australia based medical technology firm that has developed a patented nasal and respiratory technology platform capable of radically improving the way you breathe, sleep, maintain your health and take medication. The Company is focused on solving clear,...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
2013 (13 years)
Address:
NEW YORK USA, US
LOW
spending power
